Crestline Management’s Oracle ORCL Stock Holding History

Crestline Management’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,500	Closed	-$1.13M	–	134
2020 Q4	$1.13M	Buy	+17,500	New	+$1.04M	0.12%	81

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Crestline Management's ORCL Position: Q4 2024 in Review

Crestline Management sold out of Oracle (ORCL) in Q4 2024, closing a stake of 42,489 shares — an estimated $7.24M sold.

Crestline Management first reported a position in ORCL in Q4 2017 and held it in 9 quarters. The position peaked at $7.24M in Q3 2024. 3,342 funds tracked by Wall St. Rank hold ORCL as of Q4 2024.

Crestline Management reported no remaining Oracle position as of Q4 2024 after selling out during the quarter.
Crestline Management sold 42,489 Oracle shares in Q4 2024, an estimated $7.24M.
Crestline Management first reported a position in Oracle in Q4 2017 and held it in 9 quarters.
Crestline Management's Oracle position peaked at $7.24M in Q3 2024.
3,342 funds tracked by Wall St. Rank held Oracle as of Q4 2024.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.